Vitamin K Deficiency: Newborn Bleeding (VKDB)

Every baby is born with very little vitamin K, and breast milk — for all its other gifts — carries almost none. That leaves a newborn briefly unable to make some of the proteins the blood needs to clot, and a small number of these babies bleed: into the gut, from the umbilical stump, and most devastatingly into the brain. The condition is called vitamin K deficiency bleeding (VKDB), and it is one of the very few catastrophes of infancy that a single, painless injection at birth essentially erases. This page explains why newborns are uniquely vulnerable, what the bleeding looks like, why the “K shot” works so well, and why declining it is one of the riskiest choices a new parent can make.

Table of Contents

1. What VKDB Looks Like in a Baby
2. The Mechanism: Why a Newborn Can't Clot Well
3. Early, Classic, and Late VKDB
4. Honesty: Bleeding in Babies Has Other Causes Too
5. Clues That Point to Vitamin K
6. Who Is at Highest Risk
7. The Vitamin K Shot: What It Is and Why It Works
8. Oral Drops, and the Risk of Declining
9. How VKDB Is Diagnosed
10. Treating Active Bleeding
11. When to Seek Care / Red Flags
12. Key Research Papers
13. Connections
14. Featured Videos

What VKDB Looks Like in a Baby

A baby cannot tell you that something is wrong, so VKDB announces itself through bleeding that a parent or clinician sees. The presentations range from frightening-but-treatable to silently catastrophic, and what makes the condition so dangerous is that the most serious form — bleeding into the brain — can be the first and only sign, with no warning bruise beforehand.

The bleeding can show up in several ways:

• Blood in the stool or vomit — black, tarry stools or vomit that looks like coffee grounds (old blood from the gut) or frank red blood. Gastrointestinal bleeding is one of the most common presentations.
• Bleeding from the umbilical stump — oozing that won't stop, or restarts after the cord has separated.
• Bleeding after a heel-prick, circumcision, or vaccination — prolonged oozing from a small puncture that should have sealed quickly.
• Nosebleeds or bleeding from the gums and mouth.
• Unusual bruising — bruises appearing without obvious injury, or large bruises from minor handling.
• Signs of bleeding into the brain (intracranial hemorrhage) — this is the form that causes death and lifelong disability. The signs are not “bleeding” you can see; they are a baby who becomes unusually sleepy or hard to wake, feeds poorly, vomits, has a bulging or full soft spot (fontanelle) on the head, becomes pale, has a high-pitched cry, or has a seizure. A baby with any of these needs emergency care immediately.

The cruel arithmetic of VKDB is in those last bullets. Roughly half of babies who develop the late form bleed into the brain, and of those, a large fraction die or are left with permanent neurological injury — from a deficiency that costs almost nothing to prevent.

Back to Table of Contents

The Mechanism: Why a Newborn Can't Clot Well

To understand VKDB you have to understand one specific job that vitamin K does. Several of the proteins that make blood clot — the clotting factors II (prothrombin), VII, IX, and X, plus the regulatory proteins C and S — are manufactured in the liver in an inactive form. Before they can grip calcium and lock onto the surface of a forming clot, an enzyme has to add a chemical “hook” (a second carboxyl group) to specific glutamate building blocks in each protein. That reaction, called gamma-carboxylation, only works if vitamin K is present to power it. Vitamin K is the cofactor; without it, the liver still makes the clotting factors, but they come off the assembly line non-functional — present in the blood yet unable to do their job. (See Vitamin K and Blood Clotting for the full cascade.)

An analogy. Think of vitamin K as the key that activates a set of brand-new fire extinguishers (the clotting factors). The factory ships the extinguishers fully built, but with the safety pin glued in. Vitamin K is the only tool that pulls the pin. With no vitamin K, the shelves are stocked with extinguishers that look ready but cannot spray a drop — so when a fire (a bleed) starts, nothing puts it out.

Newborns are uniquely short of this key for several reasons that stack on top of each other:

• Vitamin K crosses the placenta poorly. The mother's vitamin K does not pass to the fetus efficiently, so babies are born with naturally low stores and low blood levels.
• Breast milk is very low in vitamin K. Human milk contains only about 1–4 micrograms per liter — far below what a baby needs to build up a margin of safety. (This is not a flaw to be ashamed of; breastfeeding remains strongly recommended. It simply means the vitamin K has to come from somewhere else.)
• A newborn's gut is sterile at first. In older children and adults, gut bacteria make a meaningful amount of vitamin K (the K2 form). A newborn's intestine has not yet been colonized by those bacteria, so this internal supply is essentially absent in the first days and remains low for weeks in breastfed babies.
• The immature liver stores and recycles vitamin K less efficiently than a mature one.

The result is a narrow but real window — from birth through the first several months — in which a baby's clotting system runs on a nearly empty tank. Formula-fed infants are partly protected because infant formula is fortified with vitamin K; exclusively breastfed infants who did not receive vitamin K at birth are the classic at-risk group.

Back to Table of Contents

Early, Classic, and Late VKDB

VKDB is traditionally divided into three forms by when the bleeding happens, because the timing tells you a lot about the cause and the risk.

• Early VKDB (first 24 hours). Rare, and almost always tied to the mother taking medications during pregnancy that interfere with vitamin K — certain anti-seizure drugs (phenytoin, phenobarbital, carbamazepine), some tuberculosis drugs (rifampin, isoniazid), and the blood thinner warfarin. The bleeding can be severe and is not prevented by vitamin K given to the baby after birth, so it is managed by recognizing the at-risk pregnancy in advance.
• Classic VKDB (day 2 to about day 7). The historically “classic” form, occurring in the first week, typically as bleeding from the gut, the umbilical stump, or puncture sites. It mostly affects breastfed babies who did not receive vitamin K at birth.
• Late VKDB (about 2 weeks to 6 months, peaking at 3–8 weeks). The most dangerous form. It strikes after the parents have taken a seemingly healthy baby home, almost exclusively in exclusively breastfed infants who got no vitamin K, or who got oral drops but missed doses, or who have an undiagnosed problem absorbing fat (and therefore vitamin K). Intracranial hemorrhage is the presenting sign in roughly half of late cases, which is why this form carries such a high rate of death and disability.

The late form is the heart of the modern story. Early and classic VKDB became rare once hospitals began giving vitamin K at birth; late VKDB is the form that re-emerges, sometimes in clusters, in communities where families decline the injection.

Back to Table of Contents

Honesty: Bleeding in Babies Has Other Causes Too

It would be misleading to suggest that any bleeding or bruising in a newborn means vitamin K deficiency. It does not. A baby who bleeds easily needs a careful evaluation, because several other conditions produce a very similar picture, and a few of them are emergencies in their own right:

• Inherited bleeding disorders such as hemophilia (factor VIII or IX deficiency) or von Willebrand disease — these are genetic and do not respond to vitamin K, so they have to be distinguished by specific clotting tests.
• Low platelets (thrombocytopenia) — from neonatal infection (sepsis), from antibodies crossing the placenta (alloimmune or autoimmune thrombocytopenia), or from other causes. Platelets are a different part of the clotting system from the vitamin K–dependent factors, and the treatment is different.
• Disseminated intravascular coagulation (DIC) — a severe, body-wide clotting derangement seen in very sick or septic newborns, which consumes clotting factors and platelets at once.
• Liver disease — a damaged newborn liver may fail to make clotting factors at all, regardless of vitamin K, and may also cause poor vitamin K absorption. Conditions like biliary atresia or neonatal hepatitis can present this way (see Liver Disease).
• Swallowed maternal blood — a baby who swallows the mother's blood during delivery or from a cracked nipple while breastfeeding can pass bloody stool or vomit blood without any bleeding disorder at all. A simple bedside test (the Apt test) can tell the difference.
• Non-accidental injury (abuse). Unexplained bruising or bleeding in an infant must, unfortunately, also be considered in this light.

The practical point for parents is reassuring and important at once: bleeding in a baby is taken seriously and worked up properly, so a baby who bleeds is not simply assumed to be vitamin K deficient — but neither is vitamin K deficiency ever dismissed, because it is both common in unsupplemented infants and almost completely preventable.

Back to Table of Contents

Clues That Point to Vitamin K

Certain features make vitamin K deficiency the leading suspect among the causes above, and they are the clues a clinician weighs quickly:

• The baby never received vitamin K at birth — or received oral drops and missed one or more later doses. This single fact is the strongest clue and the first question asked.
• The baby is exclusively breastfed. Formula-fed babies are largely protected by fortified formula; the unsupplemented, exclusively breastfed infant is the textbook VKDB patient.
• The timing fits — bleeding in the first week (classic) or, especially, between 2 weeks and a few months of age (late).
• The clotting tests show a specific pattern. In VKDB, the tests that measure the vitamin K–dependent factors — the prothrombin time (PT/INR) and often the activated partial thromboplastin time (aPTT) — are markedly prolonged, while the platelet count and fibrinogen are normal. That combination (prolonged clotting times with normal platelets) is highly suggestive and helps separate VKDB from thrombocytopenia and DIC.
• The bleeding stops fast after vitamin K is given. Correction of the prolonged PT within hours of a vitamin K dose is itself strong confirmation.
• There may be a hidden absorption problem. A baby with prolonged jaundice, pale stools, failure to thrive, or known cystic fibrosis may not absorb the fat-soluble vitamin K even if it was given by mouth — raising suspicion for an underlying liver or malabsorption disorder.

For the broader, all-ages picture of how low vitamin K shows up as bleeding and bruising, see the sibling page Bleeding and Easy Bruising; this page focuses specifically on the newborn.

Back to Table of Contents

Who Is at Highest Risk

VKDB does not strike at random. The babies who develop it fall into a few clear groups, and recognizing them is the whole basis of prevention:

• Babies who received no vitamin K prophylaxis at birth. This is the dominant risk factor, full stop. The rise in late VKDB in several countries over the past decade has tracked closely with parents declining the injection.
• Exclusively breastfed infants — because of the very low vitamin K content of human milk discussed above.
• Babies who got oral drops but missed doses. Oral regimens require multiple doses over weeks; a missed or vomited dose leaves a gap, and the late form often appears in exactly these babies.
• Infants with fat-malabsorption or liver/biliary disease — cystic fibrosis, biliary atresia, neonatal hepatitis, alpha-1 antitrypsin deficiency, chronic diarrhea. Because vitamin K is fat-soluble, anything that blocks fat absorption blocks vitamin K, and oral prophylaxis can fail in these babies even when given.
• Babies of mothers on interfering medications — anticonvulsants, anti-tuberculosis drugs, or warfarin during pregnancy raise the risk of the early form.
• Prolonged antibiotic exposure — broad-spectrum antibiotics suppress the gut bacteria that would otherwise begin contributing vitamin K.

The first two groups overlap heavily, and together they describe the typical late-VKDB baby: healthy-appearing, exclusively breastfed, sent home without the injection, who suddenly deteriorates at a few weeks of age.

Back to Table of Contents

The Vitamin K Shot: What It Is and Why It Works

For more than half a century, the standard of care worldwide has been a single intramuscular injection of vitamin K₁ (phytonadione) given to every newborn shortly after birth — usually 0.5 mg for babies under about 1.5 kg and 1 mg for larger babies. It is given into the thigh muscle, takes seconds, and is one of the most cost-effective preventive measures in all of medicine.

Why does a single shot work so well? The intramuscular dose does two things at once. First, it immediately tops up the baby's empty tank, providing enough vitamin K to activate the clotting factors right away — covering the classic, first-week risk. Second, and crucially, the muscle acts as a slow-release depot: the vitamin K is absorbed gradually over the following weeks, bridging the baby through the dangerous late-VKDB window until breastfeeding is established, solids begin, and the gut bacteria start contributing their own supply. One injection, in other words, covers both the early and the late threat.

The evidence behind it is among the most settled in pediatrics. A single intramuscular dose at birth has been shown for decades to prevent classic VKDB and to dramatically reduce the catastrophic late form. The historical “before-and-after” is stark: in populations that adopted universal injection, classic VKDB nearly vanished and late VKDB with brain hemorrhage became rare; in populations that abandoned or declined it, those bleeds returned. Modern reviews and the current American Academy of Pediatrics clinical report reaffirm the intramuscular injection as the standard.

A note on an old fear: in the early 1990s a single study raised a possible link between intramuscular vitamin K and childhood cancer. That alarm drove some countries toward oral dosing. It has since been thoroughly refuted — many large, careful studies found no association between vitamin K and cancer, and the major pediatric bodies regard the question as closed. Unfortunately, the original scare is still occasionally cited online; it should not weigh against a measure that prevents lethal hemorrhage.

Back to Table of Contents

Oral Drops, and the Risk of Declining

Some families ask about oral vitamin K instead of the injection. Oral regimens do exist and are used routinely in some countries, but they come with important caveats that parents deserve to hear plainly:

• Oral dosing requires multiple doses over weeks (for example, doses at birth, around 1 week, and around 4–6 weeks). A single oral dose does not reliably prevent late VKDB.
• Adherence is the weak point. A missed dose, a spit-up dose, or a baby with an unrecognized absorption problem can all leave a gap — and the late form clusters in exactly these situations. The intramuscular shot has none of these failure modes because it is given once, under observation, and absorbed slowly from the muscle.
• Oral dosing is less effective against the late form than intramuscular dosing in the published comparisons, which is why most pediatric authorities still favor the injection.

The far more consequential decision is declining vitamin K altogether. When parents refuse it, the baby is left with the empty-tank physiology described above and no backstop. Multiple countries have documented a measurable resurgence of late VKDB — including clusters of infants with intracranial hemorrhage — directly attributable to rising refusal of the injection. The medical and ethical literature is unusually blunt on this point: declining vitamin K exposes a healthy baby to a small but real chance of a preventable, often-lethal brain bleed, for no countervailing benefit. Refusal rates have been linked to misinformation (the debunked cancer scare, the idea that anything “injected” is unnatural, and confusion with vaccine debates), and correcting that misinformation is one of the highest-value conversations in newborn care.

The bottom line, stated as the major pediatric societies state it: give every newborn 1 mg of intramuscular vitamin K₁ at birth. If a family declines the injection despite counseling, an oral regimen with strict adherence is the next-best option — but it is second best.

Back to Table of Contents

How VKDB Is Diagnosed

When a young infant presents with unexplained bleeding, the workup is fast because the treatable possibilities are time-critical. The cornerstone is a set of coagulation tests — see the Coagulation Panel for the full set:

• Prothrombin time (PT) / INR — this measures the factors most dependent on vitamin K (especially II, VII, X) and is markedly prolonged in VKDB. A strikingly high PT in an otherwise well-looking baby is the signature finding.
• Activated partial thromboplastin time (aPTT) — often prolonged as well, since factor IX is also vitamin K–dependent.
• Platelet count and fibrinogen — normal in pure VKDB. This is the key discriminator: it separates VKDB (a factor problem) from low-platelet bleeding and from DIC, where platelets and fibrinogen fall.
• The PIVKA-II test (proteins induced by vitamin K absence) — a more specific marker that detects the non-functional, under-carboxylated prothrombin that accumulates when vitamin K is lacking. It is the most direct confirmation but is not available everywhere.
• A diagnostic-therapeutic trial — giving vitamin K and watching the PT correct within hours both treats the baby and confirms the diagnosis.

If the baby has signs of intracranial bleeding, brain imaging (ultrasound, CT, or MRI) is done urgently in parallel, because the bleed itself may need neurosurgical attention while the clotting is being corrected. A Complete Blood Count checks the platelet count and how much blood has been lost, and liver tests look for an underlying hepatic cause.

Back to Table of Contents

Treating Active Bleeding

Once VKDB is suspected, treatment does not wait for every result to come back — the priority is to replace vitamin K and, if bleeding is serious, to replace the missing clotting factors directly:

• Vitamin K₁ (phytonadione) is given without delay. For active bleeding it is usually given intravenously (slowly) or subcutaneously so it acts quickly; the liver can begin producing functional clotting factors within hours, and the PT typically starts to correct in 4–6 hours.
• Fresh frozen plasma (FFP) — for a baby who is actively, seriously bleeding, vitamin K alone is too slow, so plasma is transfused to supply ready-made, fully functional clotting factors immediately. This buys time while the vitamin K takes effect.
• Prothrombin complex concentrate (PCC) — a concentrated source of factors II, VII, IX, and X may be used for life-threatening hemorrhage (such as a large brain bleed) when an immediate, high-potency correction is needed.
• Red-cell transfusion — if enough blood has been lost to cause anemia or shock.
• Treating the underlying cause — if a liver or malabsorption disorder is found, it is addressed, and the baby may need ongoing vitamin K supplementation rather than a single dose.

For the babies who survive an intracranial hemorrhage, the aftermath can include neurosurgery to relieve pressure, intensive care, and a long road of developmental follow-up. This is precisely why the entire field leans so hard on prevention: treatment of established brain bleeding, however skilled, cannot undo the injury that the injection would have prevented.

Back to Table of Contents

When to Seek Care / Red Flags

For any infant — but especially one who did not receive vitamin K at birth — the following are emergencies. Call emergency services or go to the nearest emergency department immediately; do not wait for a routine appointment:

• Any bleeding that won't stop — from the umbilical stump, the nose, the mouth or gums, or a puncture site (heel-prick, circumcision, injection).
• Blood in the stool or vomit — black tarry stools, red blood, or vomit that looks like coffee grounds or contains blood.
• Unexplained or spreading bruising — bruises with no obvious cause, or out of proportion to ordinary handling.
• A baby who is unusually sleepy, floppy, or hard to wake, or who suddenly feeds poorly.
• A bulging or full soft spot (fontanelle), a high-pitched cry, persistent vomiting, sudden pallor, abnormal eye movements, or a seizure — these can signal bleeding into the brain and demand immediate care.
• Prolonged jaundice with pale (clay-colored) stools — not a bleed itself, but a warning sign of liver/biliary disease that can cause vitamin K deficiency; it warrants prompt evaluation.

The single most important protective action a parent can take is upstream of all of this: accept the vitamin K injection at birth. It is the difference between this entire page being a description of a near-eliminated disease and a description of one that is quietly returning.

Back to Table of Contents

Key Research Papers

1. Hand I, Noble L, Abrams SA (2022). Vitamin K and the Newborn Infant (AAP Clinical Report). Pediatrics;149(3):e2021056036. — DOI: 10.1542/peds.2021-056036
2. American Academy of Pediatrics, Committee on Fetus and Newborn (2003). Controversies Concerning Vitamin K and the Newborn. Pediatrics;112(1):191-192. — DOI: 10.1542/peds.112.1.191
3. Shearer MJ (2009). Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Reviews;23(2):49-59. — DOI: 10.1016/j.blre.2008.06.001
4. Araki S, Shirahata A (2020). Vitamin K Deficiency Bleeding in Infancy. Nutrients;12(3):780. — DOI: 10.3390/nu12030780
5. Sankar MJ, Chandrasekaran A, Kumar P, et al. (2016). Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. Journal of Perinatology;36(Suppl 1):S29-S35. — DOI: 10.1038/jp.2016.30
6. Puckett RM, Offringa M (2000). Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database of Systematic Reviews;(4):CD002776. — DOI: 10.1002/14651858.cd002776
7. von Kries R, Hachmeister A, Göbel U (1999). Vitamin K Deficiency Bleeding (VKDB) in Infancy. Thrombosis and Haemostasis;81(3):456-461. — DOI: 10.1055/s-0037-1614494
8. Barton DJ, et al. (1994). Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleeding. The Lancet;343(8906):1168. — DOI: 10.1016/s0140-6736(94)90277-1
9. Schulte R, Jordan LC, Morad A, et al. (2014). Late onset vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis (Tennessee, 2013). MMWR / Pediatric Neurology. — PubMed
10. Block SL (2014). Playing Newborn Intracranial Roulette: Parental Refusal of Vitamin K Injection. Pediatric Annals;43(2):53-59. — DOI: 10.3928/00904481-20131223-04
11. Kerruish N, Settle K, Robinson R (2017). The ethics of parental refusal of newborn vitamin K prophylaxis. Journal of Paediatrics and Child Health;53(1):8-11. — DOI: 10.1111/jpc.13364

PubMed Topic Searches

• PubMed — Vitamin K deficiency bleeding of the newborn
• PubMed — Late VKDB and intracranial hemorrhage
• PubMed — Intramuscular vs oral vitamin K prophylaxis
• PubMed — Parental refusal of newborn vitamin K
• PubMed — Vitamin K injection and childhood cancer (refuted)

Back to Table of Contents

Connections

• Vitamin K Deficiency Hub
• Bleeding and Easy Bruising
• Bone Health and Fractures
• Vitamin K Toxicity
• Vitamin K Overview
• Vitamin K and Blood Clotting
• Vitamin K Food Sources
• Vitamin K2
• Coagulation Panel
• Complete Blood Count
• Liver Disease
• Cystic Fibrosis
• Kale
• Spinach
• Broccoli
• Natto

Back to Table of Contents

×

Featured Videos